The Cigna Group Registered Shs Aktie 45558121 / US1255231003
277.52
USD
-4.06
USD
-1.44%
24.12.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
The Cigna Group Registered Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | The Cigna Group Registered Shs | 1.64 | 4.92 | USD |
| 2022 | The Cigna Group Registered Shs | 1.35 | 4.48 | USD |
| 2021 | The Cigna Group Registered Shs | 1.74 | 4.00 | USD |
| 2020 | The Cigna Group Registered Shs | 0.02 | 0.04 | USD |
| 2019 | The Cigna Group Registered Shs | 0.02 | 0.04 | USD |
| 2018 | The Cigna Group Registered Shs | 0.02 | 0.04 | USD |
| 2017 | The Cigna Group Registered Shs | 0.02 | 0.04 | USD |
| 2016 | The Cigna Group Registered Shs | 0.03 | 0.04 | USD |
| 2015 | The Cigna Group Registered Shs | 0.03 | 0.04 | USD |
| 2014 | The Cigna Group Registered Shs | 0.04 | 0.04 | USD |
Gewinn je Aktie- The Cigna Group Registered Shs
| 17.4 23 | 21.3 22 | 15.7 21 | 23.0 20 | 13.4 19 | 10.5 18 | 8.8 17 |
Umsatz je Aktie- The Cigna Group Registered Shs
| 657 23 | 575 22 | 511 21 | 436 20 | 405 19 | 194 18 | 163 17 |
KGV- The Cigna Group Registered Shs
| 17.2 23 | 15.6 22 | 14.6 21 | 9.1 20 | 15.2 19 | 18.0 18 | 23.2 17 |
The Cigna Group Registered Shs: Die Aktie (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 17.39 | 21.30 | 15.73 | 22.96 | 13.44 | 10.54 | 8.77 |
| Gewinn je Aktie unverwässert | 17.57 | 21.54 | 15.87 | 23.17 | 13.58 | 10.69 | 8.92 |
| Gewinn je Aktie verwässert | 17.39 | 21.30 | 15.73 | 22.96 | 13.44 | 10.54 | 8.77 |
| Dividende pro Aktie | 4.92 | 4.48 | 4.00 | 0.04 | 0.04 | 0.04 | 0.04 |
| Gesamtdividendenausschüttung in Mio. | 1’450.00 | 1’384.00 | 1’341.00 | 0.00 | 0.00 | 0.00 | 0.00 |
The Cigna Group Registered Shs: Unternehmenskennzahlen (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 657.46 | 575.03 | 511.12 | 435.82 | 404.78 | 194.10 | 163.15 |
| KGV (Jahresendkurs, EPS unverwässert) | 17.22 | 15.56 | 14.59 | 9.07 | 15.22 | 18.02 | 23.16 |
| KGV (Jahresendkurs, EPS verwässert) | 17.22 | 15.56 | 14.59 | 9.07 | 15.22 | 18.02 | 23.16 |
| KGV (Jahresendkurs) | 17.22 | 15.56 | 14.59 | 9.07 | 15.22 | 18.02 | 23.16 |
| Dividendenrendite Jahresende in % | 1.64 | 1.35 | 1.74 | 0.02 | 0.02 | 0.02 | 0.02 |
| Eigenkapitalquote in % | 31.33 | 32.13 | 31.24 | 33.42 | 30.01 | 27.68 | 24.72 |
| Fremdkapitalquote in % | 68.67 | 67.87 | 68.76 | 66.58 | 69.99 | 72.32 | 75.28 |
The Cigna Group Registered Shs: GuV (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 195’187.00 | 180’021.00 | 174’274.00 | 160’550.00 | 153’743.00 | 48’569.00 | 41’616.00 |
| Umsatzveränderung in % | 8.42 | 3.30 | 8.55 | 4.43 | 216.55 | 16.71 | 4.91 |
| Bruttoergebnis vom Umsatz | - | - | - | - | - | - | - |
| Bruttoergebnisveränderung in % | - | - | - | - | - | - | - |
| Operatives Ergebnis | 8’956.00 | 8’051.94 | 8’441.00 | 8’784.00 | 9’064.00 | 4’852.00 | 4’182.00 |
| Veränderung Operatives Ergebnis in % | 11.23 | -4.61 | -3.90 | -3.09 | 86.81 | 16.02 | 31.30 |
| Ergebnis vor Steuern | 5’513.00 | 8’353.00 | 6’782.00 | 10’868.00 | 6’570.00 | 3’581.00 | 3’606.00 |
| Veränderung Ergebnis vor Steuern in % | -34.00 | 23.16 | -37.60 | 65.42 | 83.47 | -0.69 | 21.05 |
| Ergebnis nach Steuer | 5’164.00 | 6’668.00 | 5’365.00 | 8’458.00 | 5’104.00 | 2’637.00 | 2’237.00 |
| Veränderung Ergebnis nach Steuer in % | -22.56 | 24.29 | -36.57 | 65.71 | 93.55 | 17.88 | 19.82 |
The Cigna Group Registered Shs: Bilanz (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 101’575 | 94’957 | 103’840 | 100’399 | 105’840 | 107’328 | 41’969 |
| Langzeit Gesamtverbindlichk. pro Aktie | - | - | - | - | - | - | - |
| Eigenkapital | 46’351 | 44’951 | 47’184 | 50’386 | 45’379 | 41’072 | 13’784 |
| Veränderung Eigenkapital in % | 3.01 | -4.75 | -6.38 | 10.99 | 10.51 | 198.71 | 0.09 |
| Bilanzsumme | 147’926 | 139’908 | 151’024 | 150’785 | 151’219 | 148’400 | 55’753 |
| Veränderung Bilanzsumme in % | 5.73 | -7.36 | 0.16 | -0.29 | 1.90 | 166.17 | 5.06 |
The Cigna Group Registered Shs: Sonstige Angaben (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 17.57 | 21.54 | 15.87 | 23.17 | 13.58 | 10.69 | 8.92 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -18.43 | 35.70 | -31.50 | 70.68 | 27.00 | 19.91 | 21.95 |
| Gewinn je Aktie (verwässert) | 17.39 | 21.30 | 15.73 | 22.96 | 13.44 | 10.54 | 8.77 |
| Veränderung Gewinn je Aktie (verwässert) in % | -18.33 | 35.36 | -31.47 | 70.85 | 27.51 | 20.16 | 21.97 |
| Anzahl Mitarbeiter | 72’500 | 71’300 | 73’700 | 73’700 | 73’700 | 73’800 | 46’000 |
| Veränderung Anzahl Mitarbeiter in % | 1.68 | -3.26 | 0.00 | 0.00 | -0.14 | 60.43 | 12.20 |
The Cigna Group Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| The Cigna Group Registered Shs | Quartalszahlen | 31.01.2025 |
| The Cigna Group Registered Shs | Quartalszahlen | 01.05.2025 |
| The Cigna Group Registered Shs | Quartalszahlen | 31.07.2025 |
| The Cigna Group Registered Shs | Quartalszahlen | 30.10.2025 |
The Cigna Group Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 31.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 01.08.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 02.05.2024 |
| Hauptversammlung | Annual General Meeting | 24.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 02.02.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 02.11.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 03.08.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 05.05.2023 |
| Hauptversammlung | Annual General Meeting | 26.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 03.02.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 03.11.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 04.08.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 06.05.2022 |
| Hauptversammlung | Annual General Meeting | 27.04.2022 |
| Hauptversammlung | Annual General Meeting | 27.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 03.02.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 98.10 |
| Vanguard Group, Inc. (Subfiler) | 8.93 |
| The Vanguard Group, Inc. | 8.91 |
| State Street Corp. | 4.61 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 4.20 |
| Massachusetts Financial Services Co. | 3.97 |
| Vanguard Total Stock Market ETF | 3.17 |
| Dodge & Cox | 3.16 |
| Fidelity Management & Research Co. LLC | 3.01 |
| Sanders Capital LLC | 2.84 |
| Vanguard 500 Index Fund | 2.66 |
| BlackRock Fund Advisors | 2.53 |
| BlackRock Institutional Trust Co. NA | 2.28 |
| Dodge & Cox Stock Fund | 2.14 |
| Geode Capital Management LLC | 2.11 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 46’000 | 73’800 | 73’700 | 73’700 | 73’700 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.90 | 0.66 | 2.09 | 2.18 | 2.36 |
Bilanz (in Mio. USD) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 8’073 | 20’430 | 29’845 | 27’799 | 36’134 |
| Summe Anlagevermögen | 47’680 | 127’970 | 121’374 | 122’986 | 114’890 |
| Summe Aktiva | 55’753 | 148’400 | 151’219 | 150’785 | 151’024 |
Bilanz (in Mio. USD) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 41’969 | 107’328 | 105’840 | 100’399 | 103’840 |
| Summe Eigenkapital | 13’784 | 41’072 | 45’379 | 50’386 | 47’184 |
| Summe Passiva | 55’753 | 148’400 | 151’219 | 150’785 | 151’024 |
Adresse
| 900 Cottage Grove Road, 06002-2920 Bloomfield | |
| Telefon | +1 (860) 226-6000 |
| URL | http://www.cigna.com |
Management
|
Brian C. Evanko
CFO, President & CEO-Cigna Healthcare |
|
Chris DeRosa
President-United States Government |
|
David J. Brailer
Chief Health Office & Executive Vice President |
|
David Michael Cordani
Chairman, President & Chief Executive Officer |
|
Donna F. Zarcone
Independent Director |
|
Elder Granger
Independent Director |
|
Eric C. Wiseman
Lead Independent Director |
|
Eric J. Foss
Independent Director |
|
Everett Neville
Executive VP-Strategy & Business Development |
|
George Kurian
Independent Director |
|
Jamie Kates
Chief Accounting Officer |
|
Jason D. Sadler
President-International Markets |
|
Kari Knight Stevens
Secretary, Chief Human Resources Officer & EVP |
|
Kathleen M. Mazzarella
Independent Director |
|
Kimberly A. Ross
Independent Director |
|
Mark B. McClellan
Independent Director |
|
Neesha Hathi
Independent Director |
|
Nicole S. Jones
Chief Administrative Office, EVP & General Counsel |
|
Noelle K. Eder
Global Chief Information Officer & Executive VP |
|
Paul Sanford
Executive Vice President-Operations |
|
Philip O. Ozuah
Independent Director |
|
Ralph Giacobbe
Senior Vice President-Investor Relations |
|
William J. DeLaney
Independent Director |